These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2393963

  • 1. Inhibition of hepatic microsomal cytochrome P450 by cannabidiol in adult male rats.
    Narimatsu S, Watanabe K, Matsunaga T, Yamamoto I, Imaoka S, Funae Y, Yoshimura H.
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1365-8. PubMed ID: 2393963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver.
    Narimatsu S, Watanabe K, Yamamoto I, Yoshimura H.
    Drug Metab Dispos; 1988 May; 16(6):880-9. PubMed ID: 2907469
    [Abstract] [Full Text] [Related]

  • 4. Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol.
    Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H.
    Biochem Pharmacol; 1987 Oct 15; 36(20):3371-7. PubMed ID: 3675599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
    Bornheim LM, Everhart ET, Li J, Correia MA.
    Biochem Pharmacol; 1993 Mar 24; 45(6):1323-31. PubMed ID: 8466552
    [Abstract] [Full Text] [Related]

  • 8. Effect of cannabidiol on cytochrome P-450 isozymes.
    Bornheim LM, Correia MA.
    Biochem Pharmacol; 1989 Sep 01; 38(17):2789-94. PubMed ID: 2550010
    [Abstract] [Full Text] [Related]

  • 9. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M, Field SL.
    Biochem Pharmacol; 1992 May 28; 43(10):2065-71. PubMed ID: 1599495
    [Abstract] [Full Text] [Related]

  • 10. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A, Nazar B, Nyquist S, Harclerode J.
    Drug Metab Dispos; 1977 May 28; 5(3):268-72. PubMed ID: 17525
    [Abstract] [Full Text] [Related]

  • 11. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K.
    Life Sci; 2011 Aug 01; 89(5-6):165-70. PubMed ID: 21704641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S, Okamoto Y, Yamamoto I, Watanabe K.
    Drug Metab Dispos; 2011 Nov 01; 39(11):2049-56. PubMed ID: 21821735
    [Abstract] [Full Text] [Related]

  • 14. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
    Bornheim LM, Correia MA.
    Mol Pharmacol; 1989 Sep 01; 36(3):377-83. PubMed ID: 2779523
    [Abstract] [Full Text] [Related]

  • 15. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK, Ingall GB, Karler R.
    Br J Pharmacol; 1979 Sep 01; 67(1):93-101. PubMed ID: 497524
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of biological formation of cannabielsoin from cannabidiol in the guinea-pig, mouse, rat and rabbit.
    Yamamoto I, Gohda H, Narimatsu S, Yoshimura H.
    J Pharmacobiodyn; 1989 Aug 01; 12(8):488-94. PubMed ID: 2614640
    [Abstract] [Full Text] [Related]

  • 17. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T.
    Biochem Pharmacol; 1996 Jul 26; 52(2):301-9. PubMed ID: 8694855
    [Abstract] [Full Text] [Related]

  • 18. Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein.
    Court MH, Mealey KL, Burke NS, Jimenez TP, Zhu Z, Wakshlag JJ.
    J Vet Pharmacol Ther; 2024 Jan 26; 47(1):1-13. PubMed ID: 37469115
    [Abstract] [Full Text] [Related]

  • 19. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK, Chen H, Waxman DJ.
    Drug Metab Dispos; 1994 Jan 26; 22(5):673-9. PubMed ID: 7835216
    [Abstract] [Full Text] [Related]

  • 20. Stimulatory effect of cytochrome b5 induced by p-nitroanisole and diisopropyl 1,3-dithiol-2-ylidenemalonate on rat liver microsomal drug hydroxylations.
    Kawata S, Sugiyama T, Seki K, Tarui S, Okamoto M, Yamano T.
    J Biochem; 1982 Jul 26; 92(1):305-13. PubMed ID: 6811575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.